IT·Science
Technology
SK BIOPHARMACEUTICALS Reaches Patent Settlement with U.S. Generic Drug Maker Over Excofry
SK Biopharm ( SK BIOPHARMACEUTICALS(326030)) announced on the 19th that it had reached an amicable settlement with Indian generic drugmaker MSN Laboratories (MSN) in a U.S. patent lawsuit related to “…
Technology
FLITTO Inc. Enhances Chat Translation… AI Automatically Recommends Customized Terms
FLITTO Inc.(300080)has introduced a feature that recommends terms based on AI training reports to its real-time artificial intelligence (AI) translation and interpretation solution, “Chat Translation.…
Internet
Innotena Begins Full-Scale AX Operations and Continues to Generate Profits
AX specialist MOCOMSYS(333050)(CEOs Kim In-soo and Yoon Young-ho) has recorded second-quarter 2026 revenue of 6.51 billion won and operating profit of 555 million won, marking the full-scale launch of…
Internet
KNR SYSTEMS Inc. to Develop a 1-Metric-Ton Quadruped Robot
KNR SYSTEMS Inc.(199430)has begun developing a heavy-load quadruped robot capable of carrying up to 1 metric ton of cargo and navigating rough terrain, including unpaved roads. The goal is to expand t…
Technology
Inbosa Faces Setbacks, Cartistem Succeeds… “Pain,” the Biggest Challenge, Determined Success or Failure
As TG-C (formerly Invossa) from Kolon TissueGene, Inc.(950160)failed to demonstrate pain relief in its U.S. Phase 3 clinical trial, “pain”—considered the biggest challenge in the development of osteoa…
Technology
Curiox Hits Limit-Up; CPS Overhang Weighs on OliX [K-Bio Pulse]
On Aug. 14, Curiox Biosystems hit the daily upper limit after announcing a “multi-unit” order from a global pharmaceutical company. OliX Pharmaceuticals, meanwhile, extended its losing streak to four …
Technology
Curiox Rises on 'Multi-Unit' Order… Olix Pharmaceuticals, Inc. Hindered by CPS Overhang [Bio Spotlight]
On the 14th, in the biotech and healthcare sector, Curiox hit the daily price limit following news that it had secured a “multi-unit” order from a global pharmaceutical company. Meanwhile, Olix Pharma…
Technology
A Closer Look at Kori Group’s Financial Statements Amid the ‘Accounts Receivable Controversy’… Operating Cash Flow Deficit Persists
Screenshot of the Cory Group website.
As concerns arise over the possibility that Beijing Hanmi, a Chinese subsidiary of Hanmi Group, may be unable to collect its accounts receivable, attention is…
Technology
JWPHARMACEUTICAL Goes Head-to-Head with 6mg ‘Gout Treatment’… Global Competition Also Accelerates
(Graphic: Generative AI)
JWPHARMACEUTICAL(001060)’s new gout drug candidate, “Efamynurad,” has demonstrated its competitiveness at the 6 mg dose—its primary dosage—in a multinational Phase 3 clini…
Internet
National AI Team Fails at ‘Point Allocation Design’… The Paradox of Motif’s Elimination Despite Topping the AAII Rankings [IT World Insights byKim Hyun-ah]
My first thought upon seeing the results of the second evaluation of the “Dokpamo” (Proprietary AI Foundation Model) was, “Is this correct?”This is because Motif Technologies—which ranked first among …